- Home
- BRKR vs ELAN Comparison
BRKR vs ELAN Comparison
Compare BRKR & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKR
- ELAN
- Stock Information
- Founded
- BRKR 1991
- ELAN 1954
- Country
- BRKR United States
- ELAN United States
- Employees
- BRKR 9707
- ELAN N/A
- Industry
- BRKR Biotechnology: Laboratory Analytical Instruments
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- BRKR Industrials
- ELAN Health Care
- Exchange
- BRKR Nasdaq
- ELAN Nasdaq
- Market Cap
- BRKR 8.7B
- ELAN 6.3B
- IPO Year
- BRKR 2000
- ELAN 2018
- Fundamental
- Price
- BRKR $56.56
- ELAN $13.35
- Analyst Decision
- BRKR Buy
- ELAN Buy
- Analyst Count
- BRKR 12
- ELAN 6
- Target Price
- BRKR $77.45
- ELAN $17.00
- AVG Volume (30 Days)
- BRKR 1.7M
- ELAN 4.6M
- Earning Date
- BRKR 11-05-2024
- ELAN 11-07-2024
- Dividend Yield
- BRKR 0.35%
- ELAN N/A
- EPS Growth
- BRKR N/A
- ELAN N/A
- EPS
- BRKR 2.06
- ELAN 0.41
- Revenue
- BRKR $3,241,300,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- BRKR $15.40
- ELAN $2.22
- Revenue Next Year
- BRKR $7.78
- ELAN $2.77
- P/E Ratio
- BRKR $27.69
- ELAN $32.38
- Revenue Growth
- BRKR 15.00
- ELAN 1.99
- 52 Week Low
- BRKR $48.07
- ELAN $11.40
- 52 Week High
- BRKR $94.86
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- BRKR 47.73
- ELAN 46.92
- Support Level
- BRKR $48.07
- ELAN $13.15
- Resistance Level
- BRKR $56.65
- ELAN $13.58
- Average True Range (ATR)
- BRKR 2.77
- ELAN 0.51
- MACD
- BRKR -0.16
- ELAN 0.00
- Stochastic Oscillator
- BRKR 55.07
- ELAN 41.67
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.